Design, validation, and development of novel peptidomimetic therapeutics targeting SARS-CoV-2 replication. | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
N/A
Funder
SERB India
Principal Investigator
Dr. Arockiasamy Arulandu
Research Location
India
Lead Research Institution
International Centre for Genetic Engineering and Biotechnology (ICGEB) New Delhi
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

New or repurposed antivirals against valid viral targets, viricidal coatings

2 Publications linked via Europe PMC

Last Updated:6 days ago

View all publications at Europe PMC

Modes of Binding of Small Molecules Dictate the Interruption of RBD-ACE2 Complex of SARS-CoV-2.

Zinc²⁺ ion inhibits SARS-CoV-2 main protease and viral replication in vitro.